BARCLAYS PLC - ALX ONCOLOGY HLDGS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ALX ONCOLOGY HLDGS INC
ValueSharesWeighting
Q3 2023$129
-0.8%
26,964
+57.1%
0.00%
Q2 2023$130
+85.7%
17,168
+10.4%
0.00%
Q1 2023$70
-46.2%
15,547
+34.9%
0.00%
Q4 2022$130
-99.8%
11,528
+72.7%
0.00%
Q3 2022$64,000
+88.2%
6,677
+58.5%
0.00%
Q2 2022$34,000
-57.5%
4,213
-10.5%
0.00%
Q1 2022$80,0004,7070.00%
Other shareholders
ALX ONCOLOGY HLDGS INC shareholders Q4 2023
NameSharesValueWeighting ↓
venBio Partners LLC 9,699,925$530,392,00062.60%
Logos Global Management LP 3,156,981$172,624,00014.51%
Vivo Capital, LLC 4,220,048$230,752,0009.99%
Foresite Capital Management V, LLC 231,200$12,642,0004.97%
Cormorant Asset Management, LP 889,454$48,635,0001.65%
Board of Trustees of The Leland Stanford Junior University 259,982$14,216,0001.33%
Redmile Group, LLC 914,035$49,979,0000.74%
SPHERA FUNDS MANAGEMENT LTD. 192,728$10,538,0000.71%
Financial Advisory Group 54,041$2,955,0000.71%
Nan Fung Group Holdings Ltd 34,950$1,911,0000.59%
View complete list of ALX ONCOLOGY HLDGS INC shareholders